Trial Profile
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Levomequitazine (Primary) ; Levocetirizine
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 24 Nov 2018 This trial has been completed in Spain, according to European Clinical Trials Database
- 09 Jun 2012 Actual initiation date changed from 13 Feb 2008 to 4 Dec 2007 as reported by European Clinical Trials Database.
- 09 Jun 2012 Planned end date changed from 13 May 2010 to 4 Mar 2011 as reported by European Clinical Trials Database.